Trial Profile
A retrospective study of CHEMOSAT in patients with Metastatic Uveal Melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Melphalan (Primary)
- Indications Uveal melanoma
- Focus Therapeutic Use
- 06 Jul 2016 Results published in a Delcath Systems media release.
- 06 Jul 2016 According to a Delcath Systems media release, data from this study were presented in an oral presentation at the 6th European Post-Chicago Melanoma/Skin Cancer Meeting.
- 04 Nov 2015 New trial record